Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital Würzburg, Würzburg, Germany.
Department of Psychiatry, University of Southern Denmark, Odense, Denmark.
J Neural Transm (Vienna). 2023 Sep;130(9):1091-1096. doi: 10.1007/s00702-023-02645-2. Epub 2023 May 4.
The foundation of a German Society of Biological Psychiatry (DGBP) was initiated at the Second World Congress of Biological Psychiatry of the WFSBP in Barcelona in 1978. Its mission was and is to promote interdisciplinary research on the biology of mental disorders and to translate results of biological research into clinical practice. During the presidency of Peter Falkai, its tasks were defined to improve the quality and support of biologically oriented research in Germany by the DFG (Deutsche Forschungsgemeinschaft; German Research Foundation), BMBF (Bundesministerium für Bildung und Forschung) and EU (European Union), to promote young researchers doing biologically oriented research, to improve on the diagnosis and therapy of mental disorders and to advise policy makers by taking part in legal processes. The DGBP has been a corporate member of the WFSBP from its beginning, became a cooperative member of the DGPPN (Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde), later of the German Brain Council, and fostered relationships with other scientific societies. Over the past 45 years, more than twenty congresses were held in Germany and neighboring countries. Emerging from the pandemic, the DGBP is ready to continue its mission to promote interdisciplinary research on the biology of mental disorders with a focus on the development of young scientists and to translate results of biological research into clinical practice, with regard to pharmacotherapy in close cooperation with the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP). In this sense, this article also aims to stimulate the cooperation of the society with other national and international partners and to foster new relationships with young scientists and professionals interested in the aims and goals of the DGBP.
德国生物精神病学学会(DGBP)的成立始于 1978 年在巴塞罗那举行的世界生物精神病学联合会(WFSBP)第二届世界大会。其使命是促进精神障碍生物学的跨学科研究,并将生物学研究的成果转化为临床实践。在 Peter Falkai 担任主席期间,其任务被定义为通过德国研究基金会(DFG)、联邦教育与研究部(BMBF)和欧盟(EU)提高德国以生物学为导向的研究的质量和支持,促进从事生物学导向研究的年轻研究人员,改善精神障碍的诊断和治疗,并通过参与法律程序为政策制定者提供建议。DGBP 自成立以来一直是 WFSBP 的企业成员,后来成为德国精神病学与心理治疗学会(DGPPN)、德国脑委会的合作成员,并与其他科学学会建立了关系。在过去的 45 年里,德国及周边国家举办了二十多次大会。从疫情中走出来后,DGBP 准备继续其使命,促进精神障碍生物学的跨学科研究,重点是培养年轻科学家,并将生物学研究的成果转化为临床实践,在药物治疗方面与神经精神药理学与精神药物学会(AGNP)密切合作。从这个意义上说,本文还旨在促进该学会与其他国家和国际合作伙伴的合作,并与对 DGBP 的目标和宗旨感兴趣的年轻科学家和专业人士建立新的关系。